Home › Funds › Phocas Financial Corp. › AMRX

Phocas Financial Corp. position in AMRX

AMNEAL PHARMACEUTICALS INC · Health Care

Phocas Financial Corp. reported holding 819,476 shares of AMRX (AMNEAL PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$14.2M, representing 1.97% of its reported portfolio and ranking #2 among its reported holdings. Phocas Financial Corp. has disclosed AMRX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)819.48K sh
Reported value held$14.19M
Portfolio Weight1.97%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Phocas Financial Corp.'s AMRX position evolved

Phocas Financial Corp. first disclosed a stake in AMRX in Q4 2023 at 714,890 shares (US$4.3M). The position peaked in Q4 2025 at 1,282,974 shares, worth US$16.2M. Across 11 filings, Phocas Financial Corp. increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 819,476 shares valued at US$14.2M — a reduction of -183,188 shares quarter over quarter.. Notable position changes include a 55% increase in Q2 2024 (shares rose 31% over the following quarter), a 31% increase in Q4 2024 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 714.89K $4.34M New
Q1 2024 697.08K $4.22M Reduce
Q2 2024 1.08M $6.85M Add
Q3 2024 1.02M $8.45M Reduce
Q4 2024 1.33M $10.54M Add
Q1 2025 1.26M $10.55M Reduce
Q2 2025 1.26M $10.19M Hold
Q3 2025 1.29M $12.87M Add
Q4 2025 1.28M $16.17M Hold
Q1 2026 1.00M $12.46M Reduce
Q2 2026 819.48K $14.19M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMRX and 13F data

AMRX (AMNEAL PHARMACEUTICALS INC) is a Health Care company. 47 other funds we track also report a position in AMRX — the largest reported positions include TPG GP A, LLC (US$213.4M), Rubric Capital Management LP (US$176.0M), Nantahala Capital Management, LLC (US$39.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMRX

All AMRX fund holders →

FAQ

How long has Phocas Financial Corp. held AMRX?

Phocas Financial Corp. has disclosed AMRX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is Phocas Financial Corp.'s current position in AMRX?

As of Q2 2026, Phocas Financial Corp. holds 819.48K shares of AMRX (AMNEAL PHARMACEUTICALS INC), valued at $14.19M, representing 1.97% of its reported portfolio and ranking #2.

Has Phocas Financial Corp. been buying or selling AMRX?

In the latest 13F filing (Q2 2026), Phocas Financial Corp. reduced its position in AMRX. The position peaked in Q4 2025 at 1.28M shares.

Which other funds hold AMRX?

Other major institutional holders of AMRX include TPG GP A, LLC, Rubric Capital Management LP, Nantahala Capital Management, LLC, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.